Data / Form D filings / Meadowhawk Biolabs, Inc.
Meadowhawk Biolabs, Inc.: Form D filings
Meadowhawk Biolabs, Inc., a biotechnology company in Marlborough, MA, filed 3 Form D notices with the SEC between 2023 and 2024. The latest, on July 16, 2024, reports $5 million sold of a $5 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 33 LOCKE DRIVE, SUITE 102, Marlborough, MA, 01752
- Phone
- (617) 798-6181
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1969871
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 16, 2024 | New notice | $5,000,000 | $5,000,000 | 8 | Jul 1, 2024 | sec.gov | |
| Mar 17, 2023 | New notice | $9,250,000 | $9,250,000 | 8 | Aug 9, 2021 | sec.gov | |
| Mar 17, 2023 | New notice | $6,000,000 | $6,000,000 | 9 | Mar 3, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Glick | Executive Officer, Director | |
| James Jersey | Executive Officer, Director | |
| Jessica Sullivan | Executive Officer | |
| Herbert Hooper | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 15, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Meadowhawk Biolabs, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.